These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion]. Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435 [TBL] [Abstract][Full Text] [Related]
4. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585 [TBL] [Abstract][Full Text] [Related]
5. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. Ławicki S; Mroczko B; Szmitkowski M Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691 [TBL] [Abstract][Full Text] [Related]
6. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma. Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510 [TBL] [Abstract][Full Text] [Related]
7. Significance of tumour markers in ovarian cancer. Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222 [No Abstract] [Full Text] [Related]
9. [Biomarker in gynecologic malignancies]. Isonishi S Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576 [TBL] [Abstract][Full Text] [Related]
10. Significance of tumor marker determinations in the primary therapy of ovarian cancer. Meier W; Baumgartner L; Stieber P; Hasholzner U; Fateh-Moghadam A Anticancer Res; 1997; 17(4B):2949-51. PubMed ID: 9329572 [TBL] [Abstract][Full Text] [Related]
11. [Biological markers of ovarian cancer]. Dobryszycka W Postepy Hig Med Dosw; 1986; 40(6):668-713. PubMed ID: 2440015 [No Abstract] [Full Text] [Related]
12. Comparison of the test methods (KRYPTOR, ES 600 and CIS-RIA) for CEA, CA 15-3 and CA 125 follow-up and ONCOCHECK-quality control. Bauer T; Charl S; Sturm G Anticancer Res; 2000; 20(6D):5245-7. PubMed ID: 11326703 [TBL] [Abstract][Full Text] [Related]
16. [Quality control in tumor marker values: methology, results and potential problems]. Ben Ayed M; Ben Hadj Hmida Y; Kassis M; Damak J; Masmoudi H Tunis Med; 2001; 79(6-7):341-7. PubMed ID: 11771428 [TBL] [Abstract][Full Text] [Related]